BOT 1.18% 42.0¢ botanix pharmaceuticals ltd

Ann: Half Yearly Report and Accounts, page-42

  1. WBA
    2,335 Posts.
    lightbulb Created with Sketch. 413
    So this month should see Journey medical corp report full year results in the USA
    They if course have Qbrexa, our potential competition for patients. That said IF APPROVED SB should be superior.
    Will be interesting to see annual sales, although note Japan was only approved Feb 22.
    DYOR. GLTAH
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
42.0¢
Change
-0.005(1.18%)
Mkt cap ! $761.8M
Open High Low Value Volume
43.0¢ 44.5¢ 41.5¢ $2.435M 5.697M

Buyers (Bids)

No. Vol. Price($)
20 819538 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 29052 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.